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The relationship between extrapyramidal sign (EPS) severity and cognitive function was investigated in 184 patients 
with idiopathic Parkinson’s disease (PD) and 301 normal elderly individuals from a community-dwelling cohort in 
northern Manhattan, New York City. Fifty-six of the patients with PD met criteria for dementia of the Diagnostic 
and Statistical Manzral of Mental Disorders, third edition, revised, and of the National Institute of Neurological and 
Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders Association. EPS were rated ac- 
cording to the Unified Parkinson’s Disease Rating Scale. Cognitive function was assessed by neuropsychological tests 
of memory, orientation, abstract reasoning, language, construction, and psychomotor speed. Significant associations 
were found between EPS and neuropsychological performance in PD patients without dementia. Yet EPS severity 
was unable to account for the pronounced cognitive impairment in PD dementia. Individuals in the normal group 
with subtle EPS, but without overt idiopathic PD, showed widespread cognitive changes, including impairment in 
most of the tests that differentiated PD patients from normal subjects. Prospective follow-up of these individuals will 
determine whether this represents a preclinical stage of PD or constitutes an early manifestation of dementia. 
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cognitive function in a community-dwelling cohort of patients with Parkinson’s disease and 
normal elderly individuals. Ann Neurol 1993;33:267-274 
Cognitive changes, including impairments in memory 
and in visuomotor and executive function, that accom- 
pany the motor signs of Parkinson’s disease (PD) are 
well known [ 1-41. Several studies have shown positive 
relationships between the severity of extrapyramidal 
signs (EPS) in patients with PD and the degree of cog- 
nitive impairment [ 5-91. Accordingly, this impairment 
has been linked to degeneration in the nigrostriatal 
system and to consequent impaired function of the 
“complex” caudatofugal pathway. This view is based 
on the assumption that EPS and cognitive changes in 
patients with PD share a common pathophysiological 
basis, most likely that of dopamine depletion. The 
present study critically examined the association be- 
tween EPS and neuropsychological function in nonde- 
mented patients with PD and tested 2 predictions that 
follow from it, i.e., (1) cognitive impairment is posi- 
tively and specifically associated with EPS severity in 
nondemented patients with PD, but that EPS activity 
cannot account for the severe cognitive impairment in 
patients with PD meeting ciinical criteria for dementia; 
and ( 2 )  similar (albeit milder) patterns of cognitive im- 
pairment to those found in patients with PD can be 
identified in normal individuals with subtie EPS, but 
without overt PD. Several studies have documented 
EPS in normal elderly individuals [lo-121, but the 
relationship of these signs to cognitive function has not 
been investigated. 
The present study addressed these issues using a 
population-based cohort of normal elderly individuals 
and PD patients with and without dementia in the 
Washington Heights-Inwood community of New York 
City. 
Subjects 
All subjects were drawn from the Washington Heights- 
Inwood Columbia Aging Project, a community-based pro- 
spective investigation of dementias in a geographically de- 
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fined district of New York City. Methods of PD patient 
recruitment have been described in detail [ 131. In brief, pa- 
tients with PD were identified through the development of 
a community registry for PD that used records of all patients 
seen at the Columbia Presbyterian Medical Center, contact 
with practitioners in the area unaffiliated with the center, and 
information from regional health insurance providers and the 
health resources association in the area. In addition, an- 
nouncements were placed in every local newspaper and were 
carried on television and radio programs during the recruit- 
ment period. Complete case ascertainment was assumed and 
prevalence of the condition was reported [13]. A random 
sample survey is presently underway to determine the com- 
pleteness of the registry. Normal elderly volunteers from 
the community were recruited through similar means. All 
subjects gave informed consent. 
Three subject groups were defined for statistical analysis. 
Nondemented Patients with P D  (PD-ND) 
All patients had idiopathic PD. Patients were required to 
have at least 2 of the following cardinal features of PD on 
examination or mentioned in the medical records: resting 
tremor, shuffling gait, bradykinesia, or muscular rigidity. Pa- 
tients with dementia (see below) and patients who developed 
memory loss before the motor signs of PD were excluded. 
Patients with Dementia (PO-D) 
The determination of dementia was made according to crite- 
ria of the Diagnostic and Statistical Manual of Mental Disor- 
ders, third edition, revised [14] and the National Institute of 
Neurological and Communicative Disorders and Stroke- 
Alzheimer’s Disease and Related Disorders Association [ 1 5] 
and is described in detail elsewhere [IG]. Patients with any 
other primary degenerative dementia, any secondary demen- 
tia (toxic, metabolic or traumatic), or dementia or memory 
loss before the development of motor signs were excluded. 
Normal Elderly (NE) 
No individuals in this group had dementia or a diagnosed 
neurological disorder that might affect cognitive functioning. 
For all subjects, essential tremor, stroke, and any other 
major neurological disorder were grounds for exclusion. 
Methods 
Neurological 
For patients with PD, the neurological examination was con- 
ducted by one of three attending neurologists (L.C., K.M., 
R.M.), each with extensive experience in movement disor- 
ders. EPS were recorded using the Unified Parkinson’s Dis- 
ease Rating Scale (UPDRS) { 17). Interrater reliability of the 
UPDRS was assessed on a random sample of 24 patients 
with PD. Each patient was double-rated by two of the above 
neurologists, with rater combination counterbalanced. In- 
traclass correlation coefficients and their significance levels 
were calculated using equation ICC(2,l) C181. ICCs for rigid- 
ity, bradykinesia, posture, and postural stability were in the 
0.5 to 0.6 range ( p  < 0.01) and ICCs for all other signs 
except speech and facial mobility were in the 0.6 to 0.9 range 
( p  < 0.001). ICCs for the latter two signs were not sig- 
nificant. 
For the normal elderly controls, a shortened version of the 
UPDRS was administered by a physician. This scale allowed 
the rating of speech, facial immobility, resting tremor, rigid- 
ity, posture, and bradykinesia. Interrater reliability of this 
brief scale has been established for demented patients [ 191. 
For all subjects, the short version of the Blessed Memory 
Information and Concentration Test [20) was administered 
as a brief index of mental status. Higher scores on this test 
represent greater impairment. 
Functional 
Functional capacity was rated by a physician, using Part 1 
(Sections A and B) of the Blessed Dementia Rating Scale 
(BDRS) [21), the Barthel scale [22], and the Schwab and 
England Activities of Daily Living Scale (ADL) [23]. 
Neu ropsy chological 
All tests were administered by trained examiners and testing 
was conducted in English or Spanish, according to the prefer- 
ence of the subject. Verbal memory was assessed by the 
Selective Reminding Test (SRT) [24]. The multiple choice 
recognition version of the Benton Visual Retention Test 
(BVRT) [25] was used to assess nonverbal memory. The first 
10 items of the Mini-Mental State Examination [261 allowed 
an assessment of orientation to time and place. Visuospatial 
ability was measured by the matching-to-sample version of 
the BVRT and by 5 selected items from the Rosen Drawing 
Test 1271. Language tests consisted of 15 selected items from 
the Boston Naming Test [28), 2 verbal fluency tests (the 
Controlled Oral Word Association Test [COWAT} [29] and 
Category Naming, where the subject was allowed 1 minute 
each for 3 categories, i.e., Animals, Food, and Clothing), the 
first 6 items of the Complex Ideational Material (Compre- 
hension) subtest of the Boston Diagnostic Aphasia Examina- 
tion (BDAE) [30] and the high probability Repetition items 
of the BDAE. Abstract reasoning was assessed by the Similar- 
ities subtest of the revised Wechsler Adult Intelligence Scale 
{31) and by the Identities and Oddities subtest of the Mattis 
Dementia Rating Scale [32). Finally, a cancellation task [33] 
(using a diamond shape as target and triangles, circles, and 
squares as distractors) was used to assess attention and 
speeded performance. 
Results 
Using the above inclusion and exclusion criteria, 130 
PD-ND patients (62 men, 68 women), 56 PD-D pa- 
tients (28 men, 28 women), and 307 NE individuals 
(67 men, 234 women) were retained for analysis. Eight 
subjects (6 from the NE group, 2 from the PD-ND 
group) were taking antipsychotic medication that can 
evoke EPS. These subjects were eliminated. Demo- 
graphic and clinical characteristics of the remaining 
subjects, including disease duration and current medi- 
cations for the patients in the PD groups, are shown 
in Table 1. 
Factor Analysis of the UPDRS 
Factor analysis was used to reduce the many items of 
the UPDRS to a smaller number of summary variables 
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Table I .  Group Demographic and Clinical Characteristics 
NE PD-ND PD-D 
n 301 (SD) 128 (SD) 56 (SD) 
Age (yri 75.6 (7.7) 70.6 (10.2) 78.8 (7.6) 
BDRS 1.67 (1.96) 2.55 (2.31) 7.42 (4.24) 
Barthel 1.04 (2.0) 2.16 (2.63) 6.07 (2.69) 
Schwab ADL (%) 83.7 (18.6) 76.7 (17.9) 44.5 (23.3) 
Short Blessed 4.7 (4.2) 4.9 (4.3) 14.7 (7.9) 
PD duration (yr) . . .  6.6 (6.8) 6.6 (5.8) 
Sinemet (% taking) . . .  69.9 73.6 
DA agonist (% taking) . . .  34.7 24.0 
Anticholinergic (% taking) . . .  21.4 16.3 
Education (yr) 8.1 (4.3) 10.5 (4.7) 9.4 (4.9) 
NE = normal elderly; PD-ND = nondemenced patients with Parkinson’s disease; PD-D = demented patients with Parkinson’s disease; BDRS 
= Blessed Dementia Rating Scale; ADL = Activities of Daily Living Scale; DA = dopamine. 
to simplify correlational analyses between particular 
EPS and neuropsychological performance. This was 
performed on UPDRS scores for the PD-ND and 
PD-D groups combined, using principal components 
analysis. The Kaiser-Meyer-Olkin measure of sam- 
pling adequacy {34]  was 0.91 (rated as “marvelous” 
[34]). Three factors were extracted, accounting for 
72.4% of the total variance. These were then subjected 
to oblimin rotation with Kaiser normalization. The re- 
sultant factor matrix is shown in Table 2. 
Factor 1 reflects balance and stability and also in- 
cludes gait, posture, and bradykinesia. With the excep- 
tion of bradykinesia, this factor clearly corresponds to 
the postural instability and gait difficulty (PIGD) fac- 
tor identified by Zetusky and colleagues 1351. Leg agil- 
ity showed a moderate loading on this factor. Factor 
2 consists of speeded movements (rapid alternating 
movements, hand movements, and leg agility), rigidity, 
speech, and facial expression. Rigidity may be a com- 
mon denominator across these signs. Although in- 
terrater reliability for speech and facial mobility was 
low, both these signs showed high loadings on this 
factor. Factors 1 and 2 were highly correlated ( Y  = 
- 0.66). Factor 3 clearly represents tremor and did not 
correlate with either factors 1 or 2. These three factors 
correspond, to some extent, to the classic triad of bra- 
dykinesia, rigidity, and tremor, although in the present 
case, bradykinesia was associated with instability and 
gait difficulty. 
Items from the UPDRS were then grouped ac- 
cording to these factors. To compare factor scores be- 
tween the PD-ND and PD-D groups, the three factors 
were subjected to multivariate analysis of covariance 
(MANCOVA) 1361, with group (PD-ND and PD-D) 
as a between-groups factor and age as a covariate. Ho- 
telling’s T 2  test revealed a significant group effect ( p  
< 0.001). Univariate F tests revealed that PD-D pa- 
tients had greater factor l and factor 2 scores than 
Table 2. Factor Loadings for the UPDRS 
Factor 1 Factor 2 Factor 3 
Postural stability 1.01 0.14 -0.11 
Gait 0.95 0.04 - 0.04 
Arising from chair 0.80 - 0.08 0.04 
Brad ykinesia 0.73 -0.15 0.04 
Posture 0.66 - 0.26 0.06 
Facial mobility - 0.04 - 0.86 -0.12 
Speech - 0.03 - 0.79 -0.18 
Rapid alternating 0.12 -0.76 0.15 
Hand movements 0.13 - 0.74 0.10 
Rigidity 0.09 - 0.64 0.26 
Leg agility 0.43 -0.47 0.12 
Resting tremor 0.00 0.01 0.85 
Action tremor - 0.07 0.05 0.83 
movements 
UPDRS = Unified Parkinson’s Disease Rating Scale. 
PD-ND patients (both, p < 0.001), an increase that 
could not be explained by the greater age of the pa- 
tients with dementia. 
Relationships Between EPS and Neuropsychological 
Performance: PD-ND Group 
PSYCHOLOGICAL TEST SCORES. All UPDRS items were 
summed to obtain a total EPS score for the two PD 
groups. This score was correlated with each neuropsy- 
chological test score, with coefficients adjusted for age. 
These are shown in Table 3. 
Modest correlations were found between EPS and 
memory (verbal and nonverbal), orientation, verbal 
fluency (category naming), verbal comprehension, 
drawing-to-copy (Rosen), and cancellation time. In all 
cases, the higher the EPS score, the poorer the neuro- 
CORRELATIONS BETWEEN TOTAL EPS SEVERITY AND NEURO- 
Richards et al: Extrapyramidal Signs and Cognitive Function 269 
Table 3. Peurson Cowelution Coefficients Between EPS and 
Neuropsychologicul Measures far the PD Groups 
Test PD-ND PD-D 
Immediate recall - 0.27 -0.55 
Delay recall -0.18 - 0.10 
BVRT recognition - 0.28 -0.57 
Orientation -0.34 - 0.65 
SRT 
Similarities (age scaled) - 0.05 - 0.20 
IdentitiesIOddities -0.15 - 0.5 1 
Boston Naming - 0.04 -0.52 
COWAT(mean) - 0.20 -0.53 
Category (mean) - 0.27 -0.17 
Repetition - 0.06 -0.23 
Comprehension - 0.26 - 0.43 
Rosen Drawing - 0.27 - 0.09 
BVRT matching -0.15 - 0.40 
Cancellation time 0.43 0.30 
Cancellation errors 0.09 0.2 1 
EPS = extrapyramidal signs; PD = Parkinson’s disease; PD-ND = 
nondemented patients with PD; PD-D = demented patients with 
PD; SRT = Selective Reminding Test; BVRT = Benton Visual 
Retention Test; COWAT = Controlled Oral Word Association 
Test. 
psychological performance. It can be seen chat EPS 
showed little correspondence with tests of abstract rea- 
soning, naming, repetition, and visual matching-to- 
sample. 
RELATIONSHIPS BETWEEN UPDRS FACTORS, DEMOGRAPHIC 
VARIABLES, AND NEUKOPSYCHOLOGICAL TEST SCORES. 
The three UPDRS total factor scores, along with age, 
education, PD duration, and the language in which 
neuropsychological tests were administered (English/ 
non-English), were entered into a multiple linear re- 
gression analysis, with each neuropsychological test 
score in turn as dependent variables. A stepwise proce- 
dure was used throughout. Results are summarized in 
Table 4. 
EPS were retained in the regression model for most 
neuropsychological variables. In all cases, it was factor 
2 (rigiditylmotor speed) that entered into the model. 
Factor 3 (tremor) showed a relationship with only 1 
test (positive for BVRT recognition) and factor 1 (sta- 
bility/posture/bradykinesia) showed no significant rela- 
tionships with any of the tests. None of the UPDRS 
factors entered into the model for tests of abstract rea- 
soning, naming, repetition, and visual matching. 
COMPARISON OF NEUROPSYCHOLOGICAL TEST PERFORMANCE 
BETWEEN NE AND PD-ND GROUPS. t-tests revealed that 
the NE group was significantly older ( p  < 0.001) and 
less educated ( p  < 0.001) than the PD-ND group. 
Group differences in neuropsychologicd performance 
between the normal elderly group and the PD-ND 
Table 4. Summary Multiple Regression Statisticj 
for the PD-ND Group 
Cognitive Independent 















































































































PD-ND = nondemented patients with Parkinson’s disease; SRT = 
Selective Reminding Test; BVRT = Benton Visual Retention Test; 
COWAT = Controlled Oral Word Association Test. 
group were assessed using MANCOVA, with each 
neuropsychological test score constituting dependent 
variables, group (PD-ND vs NE) as a between-groups 
factor, and age and education as covariates. The group 
effect was significant ( t 2  = 1.0, p = 0.001). Corre- 
sponding univariate F tests revealed the following tests 
to contribute to this effect: SRT ( p  = 0.008), Orienta- 
tion ( p  < 0.001), COWAT ( p  = 0.007), Category 
naming ( p  = 0.004), Rosen Drawing ( p  = 0.036), 
and Cancellation time ( p  < 0.001). In all cases, the 
performance of PD-ND patients was worse than that 
of normal subjects. All these tests were shown to cor- 
respond to EPS in the above correlational and regres- 
sion analyses. To assess possible confounding effects 
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of anticholinergic medication, this analysis was re- 
peated after excluding patients who were taking anti- 
cholinergics. With the single exception of a loss of sig- 
nificance for the Rosen Drawing Test, results were 
unchanged. 
The MANCOVA was then repeated for all PD-ND 
patients, adding the brief EPS summary score as a co- 
variate. When this covariate was added, the group ef- 
fect became nonsignificant. In fact, inspection of the 
neuropsychological test score means, adjusted for the 
covariates, indicated better performance for the PD-ND 
patients in all neuropsychological tests. This analysis 
suggests that cognitive changes in nondemented pa- 
tients with PD were specifically associated with motor 
signs of PD because they were abolished (and, to some 
extent, even reversed) when EPS activity was con- 
trolled for. 
Relationships Between EPS and Neuropsychological 
Perfomunce: PD-D Group 
PSYCHOLOGICAL TEST SCORES. Age-ad justed correlation 
coefficients were calculated for the PD-D group and 
are shown in Table 3, alongside those for the PD-ND 
group. For tests of verbal and nonverbal memory, ori- 
entation, abstract reasoning, COWAT, repetition, and 
comprehension, coefficents were larger for demented 
patients with PD than nondemented patients with PD. 
However, the reverse was true for category naming, 
drawing-to-copy, visual matching, and cancellation time. 
CORRELATIONS BETWEEN TOTAL EPS SEVERITY AND NEURO- 
COMPARISON OF NEUROPSYCHOLOGICAL TEST PERFORMANCE 
BETWEEN PD-ND AND PD-D GROUPS. t tests revealed that 
the PD-ND patients were significantly younger than 
the PD-D patients ( p  < O.OOl), but had an equal level 
of education. MANCOVA, with each neuropsycholog- 
ical test score as dependent variables, group (PD-ND 
vs PD-D) as a between-groups factor, and age and edu- 
cation as covariates revealed a highly significant group 
effect ( p  < 0.001). Corresponding F tests indicated 
poorer performance in PD-D patients at the %0.001 
level for each neuropsychological test except Repeti- 
tion and Cancellation error rate. Results were essen- 
tially unchanged when EPS was added as a covariate, 
suggesting that the cognitive deficit in PD-D cannot be 
accounted for by EPS activity. 
Comparison of Neuropsychological Test Performance 
Between NE Subjects With and Without EPS 
One hundred fourteen normal individuals (37% of the 
NE group) showed at least 1 EPS. Of these individuals, 
10 showed speech abnormalities, 17 showed reduced 
facial mobility, 11 had tremor, 25 has rigidity, 85 
showed postural abnormdty, and 48 had bradykinesia. 
In fact, 8 of these individuals met study criteria for PD 
(i.e., they had at least 2 of the cardinal motor signs of 
PD listed in Methods), but were not judged to have 
PD by the physician. 
Because of the relatively low frequency and severity 
of EPS in the NE group, the EPS score was not treated 
as a correlate in this group. Instead, NE subjects were 
dichotomized into those with EPS (EPS + ) and those 
with no evidence of EPS (EPS - ). t tests revealed that 
the EPS+ subjects were significantly older ( p  < 
0.001) and more highly educated ( p  = 0.009) than the 
EPS - subjects. In addition, EPS + subjects were more 
impaired in all three measures of functional capacity 
(BDRS, Barthel, and ADL; p < 0.001 in all cases). 
There was no difference between EPS+ and EPS- 
subjects in current use of antidepressant or anxiolytic 
medication and short Blessed mental status scores in 
these two groups were virtually identical. 
Neuropsychological test scores were subjected to 
MANCOVA, with EPS (2 ) as a between-groups fac- 
tor and age and education as covariates. The multivari- 
ate t2 test for group was significant ( p  = 0.001). Cor- 
responding univariate F tests revealed significantly 
poorer performance in EPS+ subjects than EPS- 
subjects for the following tests: SRT ( p  = 0.001), Ori- 
entation ( p  = 0.001), Similarities ( p  = 0.003), Nam- 
ing ( p  = O.Oll), COWAT ( p  = 0.0041, Category 
Naming ( p  < 0.001), BVRT matching ( p  = O.Ol>, and 
Cancellation time ( p  = 0.044). To some extent, this 
pattern of impairment reflects that found for the PD- 
N D  group, although the EPS + subjects had more dif- 
fuse cognitive changes, including those of abstract rea- 
soning, naming, and visual matching. 
Discussion 
The results of the present study provide clear evidence 
of an association between severity of EPS and degree 
of cognitive impairment in patients with PD and el- 
derly individuals without PD. 
For nondemented patients with PD, separate but 
convergent analyses revealed that this association was 
strongest with the neuropsychological tests that best 
differentiated patients with PD from normal subjects. 
These tests were those of verbal memory, orientation 
to time and place, verbal fluency (word generation), 
construction (drawing-to-copy), and psychomotor speed 
(cancellation time). With the exception of orientation 
(which has not been well investigated in patients with 
PD), selective impairments in all these domains have 
been demonstrated in P D  patients with dementia 
[l-43. However, a comprehensive model represent- 
ing convergence between neuropsychological tests 
that distinguish patients with PD from normal sub- 
jects and neuropsychological tests that correlate with 
motor signs within the same patients has not been 
previously established. There are two possible rea- 
sons for this. One  is that few large-scale studies have 
simultaneously carried out patient-control compari- 
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sons with a broadly based neuropsychological battery 
and within-patient correlations between the latter 
and motor function. Second, this convergent model 
may be associated with the population-based cohort. 
PD prevalence studies using door-to-door surveys 
have reported rates of up to 42% of cases that were 
newly diagnosed by the studies [37-391. This raises 
the possibility that patients with PD, but who have 
never sought entrance into the health care system, 
may have characteristics that are not well represented 
in clinical series. Conversely, particular clinical and 
demographic features may be overrepresented in pa- 
tients who do seek medical attention. By investigating 
PD patients identified by a community survey, the 
present results cut across these influences and un- 
cover relationships that are highly generalizable. The 
simplicity of the above model may therefore be a 
consequence of this generalizability. 
Concerning the relationship between cognitive func- 
tion and particular EPS, we found that factor analysis 
identified three EPS factors, i.e., one reflecting pos- 
ture, stability, gait, and bradykinesia, one reflecting ri- 
gidity and speeded, repetitive movements, and a third 
consisting of tremor. Although there were almost no 
associations between the first and third of these factors 
and neuropsychological performance, the rigidity/mo- 
tor speed factor showed a strong correspondence with 
neuropsychological test scores. Once again, the associa- 
tions were strong with tests that differentiated patients 
from normal subjects. It should be noted that the asso- 
ciation between factor 2 and neuropsychological im- 
pairment is in conflict with the findings of Zetusky and 
colleagues {351 and Pillon and co-workers E401. The 
former investigators reported a high correlation be- 
tween performance on a brief mental status examina- 
tion and their PIGD factor and (to a lesser extent) 
bradykinesia, but only a small correlation with rigidity. 
Consistent with this study, Pillon and co-workers C401 
found that gait disorder, but not rigidity, showed sig- 
nificant correlations with tests of memory, executive 
function, and verbal fluency. On  the other hand, stud- 
ies that have used the classic tremorlrigiditylbradykine- 
sia triad to summarize EPS in patients with PD have 
tended to show an association between cognitive func- 
tion and both rigidity and bradykinesia [b, 8, 4 1 I. An 
exception is the study by Mortimer and associates [7),  
who showed the association with bradykinesia only. 
Turning to the relationship between EPS and cogni- 
tive function in demented patients with PD, the pres- 
ent results demonstrated significant correlations be- 
tween EPS and neuropsychological performance. For 
many of these tests, coefficients were higher than those 
for the nondemented patients with PD. Because sever- 
ity of EPS was shown to be greater in demented pa- 
tients than in nondemented patients, it might be con- 
cluded that cognitive impairment in PD dementia is 
associated with increased motor involvement resulting 
from basal ganglia disease. Indeed, severity of motor 
impairment has been shown to be an important pre- 
dictor of PD dementia [42f. However, these higher 
correlations were not uniformly observed in the PD-D 
group. Indeed, correlations were actually lower than 
those in the PD-ND group for three tests (Category 
Naming, Rosen Drawing, and Cancellation time) that 
discriminated the PD-ND group from the NE group. 
Furthermore, when neuropsychological performance 
in demented patients with PD was compared with that 
of nondemented patients with PD, nearly all test 
scores were markedly lower in the demented group, 
even when these two groups were equatedfor EPS severity. 
These findings suggest that there are important con- 
tributions to dementia in PD over and above those as- 
sociated with motor impairment. Possibilities include 
Alzheimer’s disease pathology, destruction of the cho- 
linergic basal forebrain region, cortical cell loss, and the 
presence of cortical Lewy bodies. Accurate clinical- 
pathological correlation in this cohort will help to clar- 
ify the multifactorial nature of dementia in patients 
with PD. 
A striking aspect of the present study was the finding 
of cognitive impairment in normal individuals with 
EPS, but without overt PD. There is evidence that 
bradykinesia (though not rigidity) increases with age in 
normal aging [lZ]. Indeed, normal subjects with EPS 
were older than those without EPS in the present 
study. However, it is unlikely that decreased cognitive 
ability and increased motor impairment in these indi- 
viduals were merely secondary to aging, because age 
effects were controlled in our analyses. This finding 
has at least three implications. 
First, the relationship between EPS and cognitive 
impairment may be general, with a common mecha- 
nism distributed within the population, regardless of 
neurological status. This hypothesis might predict simi- 
larities in the pattern of neuropsychological impair- 
ment across different neurological diseases that present 
with EPS, such as Shy-Drager syndrome, progressive 
supranuclear palsy (PSP), cortical Lewy-body disease, 
and Alzheimer’s disease with EPS. On  this basis, it is 
interesting that there are reports of similar disturbances 
in tests of frontal lobe function in patients with PSP 
and PD [43, 441. 
Second, many of the neuropsychological tests that 
discriminated PD patients from normal subjects also 
showed the greatest impairment in normal subjects 
with EPS. It may be, therefore, that subtle EPS in nor- 
mal subjects are a preclinical marker for PD and that 
some of these normal individuals will develop a full 
PD syndrome over time (whether idiopathically or by 
interaction with an environmental insult). Recent evi- 
dence suggests that changes in handwriting and speech 
may be sensitive indicators of PD development 1451. 
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The present results suggest that other motor signs, par- 
ticularly bradykinesia, postural change, and rigidity, in 
combination with subtle andor self-reported changes 
in memory, orientation, and productive language, may 
be important in the early detection of this disease. 
Third, broader cognitive changes were demonstrated 
in normal subjects with EPS (including impaired nam- 
ing, abstract reasoning, and visual matching) than those 
observed in nondemented patients with PD. This raises 
the possibility that some of these individuals may de- 
velop PD dementia or may have an early manifestation 
of another dementia such as Alzheimer’s disease (AD). 
In fact, studies in progress at our center have demon- 
strated that EPS frequency is significantly greater in 
patients with mild AD than in normal controls C461. If 
prospective follow-up confirms a significant number of 
incident cases of PD, PD dementia, or AD among 
these individuals, then there are compelling reasons to 
incorporate assessment of EPS into the routine medical 
examination of the elderly. 
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